News
Latest news and updates from News.
News
June 5, 2026
Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya
Union Health Minister J P Nadda on Thursday declared that the Central Government remains firmly committed to strengthening healthcare infrastructure across the Northeast and ensuring that advanced medical services reach people living in remote and underserved areas of the region. Nadda made these remarks while inaugurating ARHI Hospital in Meghalaya’s Ri-Bhoi district- a new super-specialty […]
News
June 5, 2026
Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today
Mumbai-based Hexagon Nutrition Ltd has mobilised Rs 41.66 crore from anchor investors ahead of its initial public offering (IPO), which opened for public subscription on June 5 and will remain open until June 9, 2026. According to a circular uploaded on BSE’s website, the company allotted a total of 92.57 lakh equity shares to anchor […]
News
June 5, 2026
Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval
Otsuka Pharmaceutical has reported that its approved kidney disease drug Voyxact (sibeprenlimab) preserved kidney function over 12 months in a late-stage clinical study, marking a significant milestone in the treatment of immunoglobulin A nephropathy (IgAN), a serious autoimmune condition that progressively damages the kidneys. In the Phase 3 VISIONARY trial involving 320 participants, patients who […]
News
June 4, 2026
Akums Receives European CEP Approval for Cefpodoxime Proxetil
Akums Drugs & Pharmaceuticals Ltd. has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for its active pharmaceutical ingredient (API), Cefpodoxime Proxetil. The CEP certification confirms that Akums’ manufacturing process and quality standards for Cefpodoxime Proxetil comply with the requirements of the European Pharmacopoeia. The […]
News
June 4, 2026
Lupin and Natco Receive Approval from U.S. FDA for Eribulin Mesylate Injection
Lupin Limited (Lupin) and its alliance partner Natco Pharma Limited (Natco) have announced the approval from the United States Food and Drug Administration (U.S. FDA) for Natco’s Abbreviated New Drug Application (ANDA) for Eribulin Mesylate Injection, 1 mg/2 mL (0.5 mg/mL) Single-Dose Vials. Eribulin Mesylate Injection, 1 mg/2 mL (0.5 mg/mL) Single-Dose Vials is the […]
News
June 4, 2026
Maarga Mind Care launches Integrated Maternal Mental Health Program for mothers
Maarga Mind Care has introduced its Integrated Maternal Mental Health Program along with the launch of Maarga Divasa – an Integrated Day Care Program. The programs aim at addressing the emotional, psychological, and behavioral aspects of mothers during various stages of motherhood. The launch comes at a time when maternal mental health is increasingly being […]
News
June 3, 2026
Goa Among India’s Most Obese States, NFHS-6 Flags Sharp Rise in Lifestyle Diseases
Goa has emerged as one of the most obese states in India, with nearly half of its adult population now overweight or obese, according to the latest National Family Health Survey (NFHS-6) 2023-24 data. The survey, released by the Union Ministry of Health and Family Welfare, reports that 45.1% of women and 43.6% of men […]
News
June 3, 2026
Pfizer Launches Bispecific Antibody Elranatamab in India for Advanced Multiple Myeloma
Pfizer has announced the commercial launch of its bispecific antibody elranatamab in India for the treatment of adults with relapsed or refractory multiple myeloma, offering a new option for patients who have exhausted multiple prior therapies. The therapy is indicated for patients who have received at least four previous lines of treatment, including a proteasome […]
News
June 3, 2026
Alkem Laboratories has launched semaglutide in single-shot pre-filled syringes at a price starting INR350
Alkem Laboratories Ltd. (BSE: 539523, NSE: ALKEM, “Alkem” and its subsidiaries) has launched semaglutide in single-shot pre-filled syringes in multiple dose strengths at a price starting INR350. The company has received approval from the Drugs Controller General of India (DCGI) to manufacture and market semaglutide pre-filled syringes for the management of Type 2 diabetes mellitus […]
News
June 2, 2026
Oval Fertility Launched in Hyderabad
Oval Fertility, a next-gen fertility platform built at the intersection of advanced reproductive science and technology, has announced the launch of its flagship clinic in Hyderabad. Oval Fertility introduces Astec Chrono, Japan’s advanced embryo incubation technology, to India, designed to closely mimic natural developmental conditions while allowing embryologists to monitor embryo development continuously without disturbing […]
Subscribe to IMT
Join 15,000+ healthcare professionals getting our daily intelligence.
No spam. Unsubscribe anytime.
Recommended
News
June 5, 2026
Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya
News
June 5, 2026
Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today
News
June 5, 2026
Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval
News
June 4, 2026
Akums Receives European CEP Approval for Cefpodoxime Proxetil
News
June 4, 2026